Market Overview

UPDATE: Deutsche Bank Raises PT on Mead Johnson Nutrition Co. on Continued Positive Outlook

Related MJN
Zimmer Posts Q2 Earnings Beat, Revenues Miss; Guides Low
Boston Scientific Tops Q2 Earnings, Revenues; Ups EPS View

In a report published Monday, Deutsche Bank analyst Greg Poole reiterated a Buy rating on Mead Johnson Nutrition Co. (NYSE: MJN), and raised the price target from $86.00 to $94.00.

In the report, Deutsche Bank noted, “Despite a number of unexpected challenges the last 2 years, largely from China, we have been steadfast in our positive view. We still see potential upside based on China remaining a growth area, non-China EM ramping up, an eventual U.S. recovery, along with reasonable global CPG valuation and shareholder returns. We retain our BUY opinion.”

Mead Johnson Nutrition Co. closed on Friday at $85.58.

Latest Ratings for MJN

DateFirmActionFromTo
Jul 2014CitigroupMaintainsBuy
Jul 2014Credit SuisseMaintainsOutperform
Jul 2014Deutsche BankMaintainsBuy

View More Analyst Ratings for MJN
View the Latest Analyst Ratings

Posted-In: Deutsche Bank Greg PooleAnalyst Color Price Target Analyst Ratings

 

Related Articles (MJN)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters